June 27 (Reuters) - The U.S. Supreme Court's ruling on Thursday scuttling OxyContin maker Purdue Pharma's bankruptcy settlement could have a sweeping impact on how U.S. bankruptcy courts handle cases ...
In examining these rules, the court made two notable holdings. First, the court held that Rule 2003(e) does not contain a ...
The Supreme Court on Thursday ruled that a multi-billion-dollar bankruptcy plan for Purdue Pharma, the maker of the opioid OxyContin, cannot move forward. By a vote of 5-4, the justices granted the ...
None of the appellate court skepticism should encourage parties to ignore bankruptcy court orders or injunctions. Even if a bankruptcy court exceeds its authority, the reputational harm and financial ...
Fueled by financial distress in the health care and hospitality industries, a record number of businesses filed for bankruptcy in the Northern District of Texas federal courts during the first six ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback